Literature DB >> 22034122

Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability.

Nicola Dalbeth1, Keith J Petrie, Meaghan House, Jimmy Chong, Wingchi Leung, Rini Chegudi, Anne Horne, Greg Gamble, Fiona M McQueen, William J Taylor.   

Abstract

OBJECTIVE: Illness perceptions are key determinants of behavior directed at managing disease. Although suboptimal disease management has been reported in patients with gout, patients' perceptions of illness have not been systematically studied. The aim of this study was to examine illness perceptions in patients with gout.
METHODS: A total of 142 patients with gout for <10 years were recruited from primary and secondary care settings. Participants completed a gout-specific Brief Illness Perception Questionnaire, questionnaires about medication beliefs and adherence to urate-lowering therapy (ULT), and had a comprehensive assessment of gout disease activity. Serum urate, flare frequency, and Health Assessment Questionnaire (HAQ-II) scores were recorded at baseline and after 1 year.
RESULTS: Patients viewed gout as a chronic condition that was responsive to treatment but not strongly influenced by personal actions. Overall, gout was seen as having a moderate impact on their life. Most patients believed that gout was caused by dietary factors. Adherence to ULT was positively associated with a greater perceived understanding of gout and inversely associated with perceived severity and consequences of disease. Of the clinical factors assessed, pain scores were most strongly associated with negative illness perception scores at baseline. Baseline illness perception scores (perceived severity of symptoms and consequences, lower personal and treatment control) predicted worsening musculoskeletal disability at 1 year as determined by the HAQ-II. This relationship was independent of baseline disability scores.
CONCLUSION: Negative or pessimistic views about gout are associated with poorly controlled disease, lower adherence to ULT, and progression of musculoskeletal disability in patients with gout.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22034122     DOI: 10.1002/acr.20570

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  36 in total

Review 1.  Optimizing current treatment of gout.

Authors:  Frances Rees; Michelle Hui; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

2.  Allopurinol use in a New Zealand population: prevalence and adherence.

Authors:  Simon Horsburgh; Pauline Norris; Gordon Becket; Bruce Arroll; Peter Crampton; Jacqueline Cumming; Shirley Keown; Peter Herbison
Journal:  Rheumatol Int       Date:  2014-01-04       Impact factor: 2.631

Review 3.  A Systematic Review of the Economic and Humanistic Burden of Gout.

Authors:  Gemma E Shields; Stephen M Beard
Journal:  Pharmacoeconomics       Date:  2015-10       Impact factor: 4.981

Review 4.  A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases.

Authors:  Hendra Goh; Yu Heng Kwan; Yi Seah; Lian Leng Low; Warren Fong; Julian Thumboo
Journal:  Rheumatol Int       Date:  2017-07-05       Impact factor: 2.631

5.  Illness perceptions and fatigue in systemic vasculitis.

Authors:  Peter C Grayson; Naomi A Amudala; Carol A Mcalear; Renée L Leduc; Denise Shereff; Rachel Richesson; Liana Fraenkel; Peter A Merkel
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-11       Impact factor: 4.794

6.  The experience and impact of gout in Māori and Pacific people: a prospective observational study.

Authors:  Nicola Dalbeth; Meaghan E House; Anne Horne; Leanne Te Karu; Keith J Petrie; Fiona M McQueen; William J Taylor
Journal:  Clin Rheumatol       Date:  2012-11-01       Impact factor: 2.980

7.  Illness Perceptions in Chronic Lymphocytic Leukemia: Testing Leventhal's Self-regulatory Model.

Authors:  Travis D Westbrook; Eleshia J Morrison; Kami J Maddocks; Farrukh T Awan; Jeffrey A Jones; Jennifer A Woyach; Amy J Johnson; John C Byrd; Barbara L Andersen
Journal:  Ann Behav Med       Date:  2019-08-16

8.  Shared decision-making in gout treatment: a national study of rheumatology provider opinion and practice.

Authors:  Jasvinder A Singh; John S Richards; Elizabeth Chang; Karine Toupin-April; Jennifer L Barton
Journal:  Clin Rheumatol       Date:  2020-09-30       Impact factor: 2.980

9.  Self-Reported Medication Adherence in Patients With Ankylosing Spondylitis: The Role of Illness Perception and Medication Beliefs.

Authors:  Sena Tolu; Aylin Rezvani; İlhan Karacan; Derya Bugdayci; Habib Can Küçük; Ömer Faruk Bucak; Teoman Aydin
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

Review 10.  A patient-centered gout information value chain: a scoping review.

Authors:  Maranda J Russell; Sujin Kim; Aleksander Lenert
Journal:  Patient Educ Couns       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.